A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma
Future Oncology, Ahead of Print.
Source: Future Oncology - Category: Cancer & Oncology Authors: Martin Dreyling Constantine S Tam Michael Wang Stephen D Smith Marco Ladetto Huiqiang Huang William Novotny Melannie Co Alfredo Romano Eric Holmgren Jane Huang Steven Le Gouill Source Type: research